Peer Exchange: Diabetes Stakeholders Summit

home / publications / evidence-based-diabetes-management / peer-exchange-spring-2017-diabetes

Finding Value in Today's New Insulins, GLP-1 Combinations

Mary Caffrey

July 20th 2017

ArticleEvidence-Based Diabetes Management

Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.

From Unexpected CV Benefits to Potential in Heart Failure: Insights and Outlook for SGLT2 Inhibitors

Mary Caffrey

July 20th 2017

ArticleEvidence-Based Diabetes Management

Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.

Can SGLT2 Inhibitors Prevent Heart Failure in a Broad Population?

Mary Caffrey

July 18th 2017

ArticleEvidence-Based Diabetes Management

A study presented at the 2017 Scientific Session of the American College of Cardiology uses claims data to examine whether SGLT2 inhibitors offer a protective benefit against heart failure.

With Rise of Diabetes Technology Comes Value-Based Payment

Mary Caffrey

July 18th 2017

ArticleEvidence-Based Diabetes Management

Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions